Microbix Historical Financial Ratios
MBX Stock | CAD 0.30 0.01 3.45% |
Microbix Biosystems is lately reporting on over 92 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 82.59 will help investors to properly organize and evaluate Microbix Biosystems financial condition quickly.
Microbix |
About Microbix Financial Ratios Analysis
Microbix BiosystemsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Microbix Biosystems investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Microbix financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Microbix Biosystems history.
Microbix Biosystems Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Microbix Biosystems stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Microbix Biosystems sales, a figure that is much harder to manipulate than other Microbix Biosystems multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Microbix Biosystems dividend as a percentage of Microbix Biosystems stock price. Microbix Biosystems dividend yield is a measure of Microbix Biosystems stock productivity, which can be interpreted as interest rate earned on an Microbix Biosystems investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Most ratios from Microbix Biosystems' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Microbix Biosystems current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microbix Biosystems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Microbix Biosystems' ROIC is very stable compared to the past year. As of the 23rd of July 2025, Inventory Turnover is likely to grow to 2.18, while Price To Sales Ratio is likely to drop 1.97.
2024 | 2025 (projected) | Dividend Yield | 3.09 | 1.97 | Price To Sales Ratio | 2.07 | 1.97 |
Microbix Biosystems fundamentals Correlations
Click cells to compare fundamentals
Microbix Biosystems Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Microbix Biosystems fundamentals Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Price To Sales Ratio | 2.59 | 3.89 | 3.62 | 1.8 | 2.07 | 1.97 | |
Ptb Ratio | 3.9 | 2.77 | 1.74 | 1.62 | 1.86 | 1.77 | |
Days Sales Outstanding | 82.56 | 59.11 | 92.3 | 60.21 | 69.24 | 82.59 | |
Free Cash Flow Yield | 0.0111 | 0.0209 | (0.0494) | 0.0533 | 0.048 | 0.0504 | |
Operating Cash Flow Per Share | 0.0183 | 0.0256 | (0.007937) | 0.0318 | 0.0286 | 0.0301 | |
Stock Based Compensation To Revenue | 0.0203 | 0.0341 | 0.0445 | 0.0281 | 0.0323 | 0.0349 | |
Capex To Depreciation | 1.18 | 1.58 | 1.95 | 0.88 | 1.06 | 1.87 | |
Pb Ratio | 3.9 | 2.77 | 1.74 | 1.62 | 1.86 | 1.77 | |
Ev To Sales | 3.77 | 3.22 | 2.29 | 1.54 | 1.78 | 1.69 | |
Free Cash Flow Per Share | 0.007002 | 0.0106 | (0.0153) | 0.0179 | 0.0161 | 0.0169 | |
Roic | 0.0927 | 0.0839 | (0.0867) | 0.11 | 0.0965 | 0.1 | |
Inventory Turnover | 1.71 | 1.5 | 1.57 | 1.55 | 1.78 | 2.18 | |
Net Income Per Share | 0.0142 | 0.0132 | (2.86E-4) | 0.0258 | 0.0232 | 0.0243 | |
Days Of Inventory On Hand | 213.11 | 242.6 | 232.41 | 235.89 | 271.28 | 286.37 | |
Payables Turnover | 4.21 | 4.35 | 4.34 | 3.76 | 3.38 | 2.1 | |
Research And Ddevelopement To Revenue | 0.0963 | 0.0556 | 0.0943 | 0.12 | 0.0837 | 0.0914 | |
Capex To Revenue | 0.0773 | 0.0701 | 0.11 | 0.0615 | 0.0751 | 0.0863 | |
Cash Per Share | 8.84E-4 | 0.087 | 0.0996 | 0.0842 | 0.0948 | 0.11 | |
Pocfratio | 34.34 | 19.92 | (39.06) | 10.53 | 9.48 | 9.01 | |
Interest Coverage | 3.02 | 3.26 | (3.26) | 4.24 | 3.81 | 4.0 | |
Capex To Operating Cash Flow | 0.62 | 0.58 | (0.93) | 0.44 | 0.39 | 0.37 | |
Pfcf Ratio | 89.97 | 47.96 | (20.25) | 18.76 | 21.58 | 22.65 | |
Days Payables Outstanding | 86.79 | 83.94 | 84.05 | 97.15 | 111.73 | 177.79 | |
Income Quality | 0.65 | 1.94 | 27.72 | 1.24 | 1.11 | 1.06 | |
Roe | (0.94) | 0.0879 | 0.0717 | (0.001603) | 0.12 | 0.11 | |
Ev To Operating Cash Flow | 33.27 | 17.71 | (34.53) | 9.02 | 8.12 | 7.71 | |
Pe Ratio | 44.38 | 38.6 | (1.1K) | 13.01 | 14.96 | 14.21 | |
Return On Tangible Assets | 0.06 | 0.0565 | (0.001264) | 0.1 | 0.0935 | 0.0982 | |
Ev To Free Cash Flow | 87.17 | 42.64 | (17.9) | 16.07 | 18.48 | 19.41 | |
Earnings Yield | 0.0225 | 0.0259 | (9.24E-4) | 0.0769 | 0.0692 | 0.0726 | |
Intangibles To Total Assets | 0.11 | 0.0573 | 0.0452 | 0.12 | 0.13 | 0.21 | |
Net Debt To E B I T D A | (0.4) | (2.06) | (2.54) | (1.06) | (0.95) | (1.0) | |
Current Ratio | 3.68 | 8.45 | 5.13 | 7.15 | 6.43 | 6.75 | |
Tangible Book Value Per Share | 0.0575 | 0.0465 | 0.15 | 0.17 | 0.18 | 0.16 |
Pair Trading with Microbix Biosystems
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Microbix Biosystems position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microbix Biosystems will appreciate offsetting losses from the drop in the long position's value.Moving together with Microbix Stock
Moving against Microbix Stock
0.87 | AUAU | Allegiant Gold Split | PairCorr |
0.81 | NVDA | NVIDIA CDR | PairCorr |
0.79 | RKV | Rakovina Therapeutics Split | PairCorr |
0.78 | GOOG | Alphabet CDR | PairCorr |
0.77 | AMZN | Amazon CDR | PairCorr |
The ability to find closely correlated positions to Microbix Biosystems could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microbix Biosystems when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microbix Biosystems - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microbix Biosystems to buy it.
The correlation of Microbix Biosystems is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microbix Biosystems moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microbix Biosystems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microbix Biosystems can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Microbix Stock
Microbix BiosystemsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Microbix Biosystems investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Microbix financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Microbix Biosystems history.